Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,454,800 | $2,645,500 | $2,431,000 | $2,454,700 |
| % Growth | -7.2% | 8.8% | -1% | – |
| Cost of Goods Sold | $876,600 | $946,200 | $577,900 | $583,500 |
| Gross Profit | $1,578,200 | $1,699,300 | $1,853,100 | $1,871,200 |
| % Margin | 64.3% | 64.2% | 76.2% | 76.2% |
| R&D Expenses | $369,600 | $529,900 | $545,900 | $683,500 |
| G&A Expenses | $0 | $0 | $0 | $611,900 |
| SG&A Expenses | $594,800 | $581,300 | $574,600 | $678,700 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $66,800 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $964,400 | $1,111,200 | $1,120,500 | $1,362,200 |
| Operating Income | $613,800 | $588,100 | $732,600 | $509,000 |
| % Margin | 25% | 22.2% | 30.1% | 20.7% |
| Other Income/Exp. Net | -$56,500 | $155,900 | -$421,400 | -$217,500 |
| Pre-Tax Income | $557,300 | $744,000 | $311,200 | $291,500 |
| Tax Expense | $90,800 | $109,200 | $70,700 | $24,800 |
| Net Income | $466,500 | $634,800 | $240,500 | $266,700 |
| % Margin | 19% | 24% | 9.9% | 10.9% |
| EPS | 3.18 | 4.35 | 1.65 | 1.83 |
| % Growth | -26.9% | 163.6% | -9.8% | – |
| EPS Diluted | 3.17 | 4.35 | 1.64 | 1.83 |
| Weighted Avg Shares Out | 146,600 | 145,900 | 145,900 | 145,700 |
| Weighted Avg Shares Out Dil | 147,100 | 145,900 | 145,900 | 146,100 |
| Supplemental Information | – | – | – | – |
| Interest Income | $31,600 | $32,300 | $23,900 | $18,500 |
| Interest Expense | $67,400 | $72,600 | $60,000 | $60,000 |
| Depreciation & Amortization | $202,200 | $194,300 | $183,200 | $184,000 |
| EBITDA | $826,900 | $1,109,900 | $865,100 | $691,700 |
| % Margin | 33.7% | 42% | 35.6% | 28.2% |